Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb;19(2):191-205.
doi: 10.1007/s00775-013-1059-4. Epub 2013 Nov 20.

Comparison of divalent transition metal ion paraCEST MRI contrast agents

Affiliations
Review

Comparison of divalent transition metal ion paraCEST MRI contrast agents

Sarina J Dorazio et al. J Biol Inorg Chem. 2014 Feb.

Abstract

Transition-metal-ion-based paramagnetic chemical exchange saturation transfer (paraCEST) agents are a promising new class of compounds for magnetic resonance imaging (MRI) contrast. Members in this class of compounds include paramagnetic complexes of Fe(II), Co(II), and Ni(II). The development of the coordination chemistry for these paraCEST agents is presented with an emphasis on the choice of the azamacrocycle backbone and pendent groups with the goals of controlling the oxidation state, spin state, and stability of the complexes. Chemical exchange saturation transfer spectra and images are compared for different macrocyclic complexes containing amide or heterocyclic pendent groups. The potential of paraCEST agents that function as pH- and redox-activated MRI probes is discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Crystal structures of A) [Mn(TCMC)]2+and B) [Yb(TCMC)(H2O)]3+. Reprinted with permission from references [38] and [37], respectively.
Figure 2
Figure 2
A) 1H NMR spectra for [Fe(TCMC)]2+ in CD3CN and B) [Yb(TCMC)(H2O)]3+ in H2O. The * indicates the location of amide NH protons. The broad proton resonances are assigned as macrocycle CH protons. Adapted with permission from references [40] and [37].
Figure 3
Figure 3
Crystal structure of [Ni(TCMT)]2+. Reprinted with permission from reference [45].
Figure 4
Figure 4
A) 1H NMR spectra of [Fe(AMPT)]2+ in D2O, pD 7.0, (B) [Ni(NOPE)]2+ in D2O. Adapted with permission from references [22, 25].
Figure 5
Figure 5
Crystal structures of A) deprotonated [Ni(H–2BZT)], (B) [Ni(TPT)]2+ (C) [Zn(TPT)]2+ showing complex cation geometry. Adapted with permission from references [–57].
Figure 6
Figure 6
Illustration of a 1H NMR spectrum of a CEST agent (top), corresponding CEST spectrum (middle), and representation of water signal intensity (bottom). Reprinted with permission from reference [61].
Figure 7
Figure 7
CEST spectra of A) [Fe(STHP)]2+ (○) and [Fe(TCMC)]2+ (▲); B) [Ni(CCRM)]2+ (◇) and [Ni(NOPE)]2+ (○); C) [Co(NOPE)]2+ (○) and [Co(TCMC)]2+ (▲); D) [Ni(TCMT)]2+ (▲), [Fe(TCMT)]2+ (⋄), and [Co(TCMT)]2+ (○). All samples contained 10 mM complex, 20 mM HEPES buffer pH ~7.4, and 100 mM NaCl B1 = 24 μT (1000 Hz) presaturation for 2 s at 37 ºC,. CEST spectra modified from references [22, 23, 25, 26].
Figure 8
Figure 8
CEST spectra (11.7 T NMR) of 4 mM [Fe(AMPT)]2+ (black line), 100 mM NaCl, pH 7.0 (B1= 11 μT, 4 s, 25 ºC); 3mM [Fe(BZT)]2+ (red line), 100 mM NaCl, pH 6.3 (B1= 23 μT, 3 s, 25 ºC); and 8 mM [Co(TPT)]2+ (blue line), 100 mM NaCl, 20 mM HEPES, pH 7.0 (B1= 24 μT, 3 s, 37 ºC). Insert shows expanded CEST spectrum of [Fe(AMPT)]2+ [21, 22, 24].
Figure 9
Figure 9
Phantom images of [Ni(NOPE)]2+ on a 4.7 T MR scanner. Center contains only 20 mM HEPES,100 mM NaCl. Concentration of [Ni(NOPE)]2+ varies: D1 2mM, D2 4mM, and D3 8 mM with 20 mM HEPES pH~ 7.4, 100 mM NaCl at 37º C. Reprinted with permission from reference [25].
Figure 10
Figure 10
Transition metal ions to date that show promise as paraCEST agents.
Scheme 1
Scheme 1
Divalent transition metal ion-based paraCEST agents.
Scheme 2
Scheme 2
Macrocyclic complexes with pyridine pendents
Scheme 3
Scheme 3
Representative LnIII paraCEST agents

References

    1. McRobbie DW, Moore EA, Graves MJ, Prince MR. MRI: From Picture to Proton. Cambridge University Press; Cambridge: 2007.
    1. Benveniste H, Blackband S. Prog Neurobiol. 2002;67:393–420. - PubMed
    1. Strijkers GJ, Mulder WJM, van Tilborg GAF, Nicolay K. Anti-Cancer Agents Med Chem. 2007;7:291–305. - PubMed
    1. Massoud TF, Gambhir SS. Genes Dev. 2003;17:545–580. - PubMed
    1. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Chem Rev. 1999;99:2293–2352. - PubMed

Publication types

MeSH terms